Cargando…

Symptomatic Characteristics of Parkinson's Disease Induced by Neuroleptic Drugs, Based on a Functional Neuroimaging Diagnosis

OBJECTIVE: When patients take neuroleptics, the distinction between Parkinson's disease (PD) and drug-induced parkinsonism (DIP) based solely on clinical features can become difficult. At present, (123)I-FP-CIT SPECT (DAT-SPECT) and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tachibana, Kei, Matsuura, Keita, Shindo, Akihiro, Matsuyama, Hirofumi, Ii, Yuichiro, Taniguchi, Akira, Tomimoto, Hidekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056363/ https://www.ncbi.nlm.nih.gov/pubmed/32062624 http://dx.doi.org/10.2169/internalmedicine.2553-18

Ejemplares similares

MEFV gene mutations in neuro‐Behçet's disease and neuro‐Sweet disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2019)

Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report
por: Sakano, Shoko, et al.
Publicado: (2020)

Pulvinar quantitative susceptibility mapping predicts visual hallucinations post‐deep brain stimulation in Parkinson's disease
por: Matsuura, Keita, et al.
Publicado: (2023)

Micro-MRI improves the accuracy of clinical diagnosis in cerebral small vessel disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2021)

Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study
por: Matsushita, Futoshi, et al.
Publicado: (2018)

Association between behavioral and psychological symptoms and cerebral small vessel disease MRI findings in memory clinic patients
por: Shinohara, Masaki, et al.
Publicado: (2023)

Background and distribution of lobar microbleeds in cognitive dysfunction
por: Matsuyama, Hirofumi, et al.
Publicado: (2017)

Clinical Features and Experimental Models of Cerebral Small Vessel Disease
por: Shindo, Akihiro, et al.
Publicado: (2020)

Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
por: Matsuyama, Hirofumi, et al.
Publicado: (2021)

Investigation of hypertensive arteriopathy-related and cerebral amyloid angiopathy-related small vessel disease scores in patients from a memory clinic: a prospective single-centre study
por: Matsuda, Kana, et al.
Publicado: (2021)

Vertebral artery dissection associated with familial Mediterranean fever and Behçet's disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2019)

Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Cerebral Embolism Associated with Calcified Amorphous Tumor: A Review of Cerebral Infarction Cases
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Magnetic resonance imaging and neuropsychological findings for predicting of cognitive deterioration in memory clinic patients
por: Matsuda, Kana, et al.
Publicado: (2023)

Deep Brain Stimulation in a Patient with Parkinson's Disease and Cortical Superficial Siderosis
por: Shiraishi, Makoto, et al.
Publicado: (2022)

Impairment of intermediate somatosensory function in corticobasal syndrome
por: Matsuda, Kana, et al.
Publicado: (2020)

Microbleeds after Carotid Artery Stenting: Small Embolism May Induce Cerebral Microbleeds
por: Ogawa Ito, Ai, et al.
Publicado: (2019)

Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology
por: Niwa, Atsushi, et al.
Publicado: (2017)

Reversible splenial lesion in a patient with new-onset refractory status epilepticus (NORSE)
por: Mizutani, Akane Unno, et al.
Publicado: (2019)

Proposition of zinc supplementation during levodopa–carbidopa intestinal gel treatment
por: Matsuyama, Hirofumi, et al.
Publicado: (2018)

Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient
por: Miyashita, Koichi, et al.
Publicado: (2023)

Parkinson disease and Neuroleptic withdrawal
por: Jambunathan, Stephen, et al.
Publicado: (2010)

Relationship of brain edema after deep brain stimulation surgery with motor and cognitive function
por: Nishiguchi, Yamato, et al.
Publicado: (2022)

Neuroleptic‐induced Parkinsonism: Clinicopathological study
por: Shuaib, Umar A., et al.
Publicado: (2015)

Brain magnetic resonance imaging and cognitive alterations after ablation in patients with atrial fibrillation
por: Kato, Natsuko, et al.
Publicado: (2021)

Imaging Characteristics for Predicting Cognitive Impairment in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
por: Taniguchi, Akira, et al.
Publicado: (2022)

Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy
por: Hirata, Yoshinori, et al.
Publicado: (2022)

Re-emergent Tongue Tremor in Neuroleptic-induced Parkinsonism
por: Prasad, Shweta, et al.
Publicado: (2019)

Low Pulvinar Intensity in Susceptibility-Weighted Imaging May Suggest Cognitive Worsening After Deep Brain Stimulation Therapy in Patients With Parkinson's Disease
por: Matsuura, Keita, et al.
Publicado: (2019)

Chronic recurrent multifocal osteomyelitis mimicking migraine
por: Taniguchi, Akira, et al.
Publicado: (2023)

Identifying and Characterizing People with Dementia Not Accessing the Japanese Community-Based Integrated Care System Using Health Insurance Claims Data
por: Mizutani, Akane, et al.
Publicado: (2022)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis
por: Dean, Derek J, et al.
Publicado: (2015)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Neuroimaging in Vascular Parkinsonism
por: Ma, Karen K. Y., et al.
Publicado: (2019)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism
por: Kotomin, Ivan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rcnjfi7ufgtmfqrkrj612fpras